News

Biosfer Teslab news

Science outreach on lipoproteins, metabolomics and cardiometabolic health, the studies we take part in and the team’s collaborations. Each news item has its own page to share or cite.

63 news items
News and knowledgeSelect to read
NewsMenopause and cardiovascular health: looking beyond traditional risk factorsThe menopausal transition involves hormonal, metabolic and vascular changes that may influence women’s cardiovascular health. Understanding these changes from an integrated perspective may open new opportunities for…NewsletterNewsletter · Q3 2026During the third quarter of 2026, Biosfer Teslab continued to make steady progress in research, innovation, and scientific collaboration. We strengthened our commitment to advancing precision medicine through the…NewsXULA 2026: lipid research and cardiovascular preventionConnecting lipid research, clinical practice and cardiovascular prevention through the collaborative ecosystem of LIRIC, UVASMET, URLA/URV and Biosfer Teslab.NewsWorld Heart Day 2026: Prevention and Cardiovascular RiskCardiovascular diseases remain the leading cause of death worldwide. September 29 is an opportunity to remember that understanding our cardiovascular risk factors, detecting them early and taking action can make a…NewsFamilial Hypercholesterolemia: The Importance of Early DetectionFamilial hypercholesterolemia is an inherited condition that causes elevated LDL cholesterol levels from an early age. Early identification is key to reducing cumulative cholesterol exposure and addressing…NewsIcosapent ethyl and residual cardiovascular risk: what NMR reveals beyond triglyceridesA prospective, multicentre real-world study shows that icosapent ethyl therapy is associated with favourable changes in atherogenic lipoprotein particles and in an integrated marker of systemic inflammation. The key is…NewsMASLD: A Metabolic Disease with Growing Cardiovascular ImpactMetabolic dysfunction-associated steatotic liver disease (MASLD), formerly known as non-alcoholic fatty liver disease (NAFLD), has become one of the fastest-growing metabolic disorders worldwide.Its prevalence is rising…NewsThe Lipid Silhouette: A Visual Snapshot of Cardiovascular Risk in the Liposcale ReportVisualizing cardiovascular risk in a single image As science advances, the amount of data generated to assess cardiovascular risk (CVR) continues to grow, including the composition, size, and number of lipoprotein…NewsThe Number of LDL Particles: The Hidden Metric That Explains True Atherosclerotic Risk in DyslipidemiaLDL-C as a Traditional Therapeutic Target Historically, LDL-C has been maintained as the primary therapeutic target in the prevention of atherosclerotic cardiovascular disease (ASCVD), with the goal of reducing its…NewsLow-Grade Inflammation and Glycoproteins: New Evidence After Metabolic SurgeryLow-Grade Inflammation: The Invisible Thread Connecting Obesity and Cardiometabolic Risk Obesity is not merely an excess of weight; it is a complex disease associated with a chronic, low-grade inflammatory state—silent…NewsObesity Affects Men and Women Differently: New Insights into the Lipoprotein ProfileA recent study published in Lipids in Health and Disease (Santisteban et al., 2025) offers a new perspective on how sex and body mass index influence lipoprotein metabolism, even in individuals considered metabolically…NewsGut microbiota and metabolism associated with CAR-T therapy response in multiple myelomaA recent work published by Mireia Uribe-Herranz¹⁺², Aina Oliver-Caldés¹⁺³, Neus Martínez-Micaelo⁴, Marta Español-Rego², Maria Val-Casals¹⁺⁵, Roberto Martínez-Soler¹, Elisa Rubio-Garcia⁶⁺⁷⁺⁸⁺⁹, Valeria Brunello¹, Erik Z…NewsTriglycerides: More Than a Marker — A Driver of Cardiovascular RiskIntroduction: The Residual Risk Beyond LDL Cholesterol For decades, LDL cholesterol has been considered the main enemy in cardiovascular prevention. However, numerous studies — including the FOURIER-OLE trial — have…NewsASCAHIFA and Biosfer Teslab on Familial Hypercholesterolemia DayASCAHIFA and Biosfer Teslab join forces to advance the diagnosis of familial hypercholesterolemia with Liposcale® On September 24, we celebrate Familial Hypercholesterolemia (FH) Day, a hereditary genetic condition that…NewsWhen LDL Cholesterol Doesn’t Tell the Whole Story: A Clinical Case of Hidden Cardiovascular RiskThe Challenge of Residual Risk in Cardiovascular Health Cardiovascular diseases remain the leading cause of death worldwide.Despite preventive efforts—such as controlling LDL cholesterol, blood pressure, and glucose…NewsNMR Metabolomics in Animal Models: A Key Tool for Translational ResearchIn biomedical research, animal models represent a fundamental tool for understanding the pathophysiological mechanisms of human diseases and for exploring new therapeutic strategies. They allow for the controlled…NewsLiposcale and Glycoscale in Cardiovascular Risk Prediction in Type 2 DiabetesEach year, cardiovascular diseases (CVD) are responsible for more than 4 million deaths in Europe, making them the leading cause of mortality on the continent. These diseases include heart attacks, strokes, and other…NewsBeyond LDL: A Comprehensive Approach to Cardiovascular HealthEach year, cardiovascular diseases (CVD) are responsible for more than 4 million deaths in Europe, making them the leading cause of mortality on the continent. These diseases include heart attacks, strokes, and other…NewsExploring New Frontiers in Biomarker Analysis: NMR in Multiple Biological MatricesNuclear magnetic resonance (NMR) is an advanced technology that allows the analysis of various biological matrices, from blood and urine to less conventional bodily fluids such as breast milk. This ability to explore…NewsMetabolomics in Sports: Applications in Performance and RecoveryMetabolomics has emerged in recent years as a powerful tool for the comprehensive assessment of biochemical changes occurring in the body during physical exercise. It is based on the analysis of metabolites, small…NewsNutrition and Cardiovascular Health: Reflections on World Food DayThis year, the Food and Agriculture Organization of the United Nations (FAO) has chosen the theme «The Right to Food for a Better Life and Future» to commemorate World Food Day (October 16). This theme emphasizes the…NewsThe Revolution of Data Analysis in HealthcareData analysis has become a fundamental pillar for decision-making in healthcare. As the volume and complexity of clinical, genetic, epidemiological, and public health data grow exponentially, the ability to effectively…NewsFamilial Hypercholesterolemia and the Importance of Metabolomics for Its Detection and Personalized TreatmentToday, on International Familial Hypercholesterolemia (FH) Day, we want to highlight this genetic condition that affects millions of people worldwide and can lead to severe cardiovascular complications if not diagnosed…NewsRole of Metabolomics in Infectious Diseases: A Cross-sectional ApproachMetabolomics is becoming a crucial tool in biomedical research. By analyzing the complete set of metabolites present in a biological sample, such as serum, plasma, or urine, among others, metabolomics offers a direct…NewsImportance of LDL Cholesterol in Bariatric Surgery TechniquesA recent study led by Dr. David Benaiges (1,2,3,4,5) from the Bariatric Surgery Unit at Hospital del Mar, in collaboration with Albert Goday (1,3,5,6), Anna Casajoana (3,7), Juana A. Flores-Le Roux (1,2,3), Montserrat…NewsThe Rising Role of Metabolomics in Clinical TrialsThe integration of metabolomics into clinical trials is revolutionizing medical research by providing detailed insights into the biochemical changes associated with various diseases and treatments. Metabolomics, the…NewsUncovering Biomarkers for Optimal Athletic PerformanceMetabolomics, an emerging field that studies the metabolites within our bodies, is revolutionizing our understanding of how exercise affects our health and athletic performance by uncovering biomarkers to maximize our…NewsCardiovascular Risk in Lupus Patients through NMRLupus, a chronic autoimmune disease, is closely associated with an elevated risk of cardiovascular diseases, one of the main causes of mortality in these patients. Chronic inflammation and the autoimmune response that…NewsNMR: A Look into the Future for Biomedical ResearchNuclear Magnetic Resonance (NMR) has been a key tool in biomedical research and the study of metabolism and metabolic processes for nearly half a century. With its ability to perform metabolic studies, metabolic…NewsBiosfer Teslab and AM BIOTA: Alliance for Personalized MedicineIn a milestone for scientific advancement, Biosfer Teslab and AM BIOTA announce a unique collaboration to develop a groundbreaking gut -omic test. This project will integrate the cutting edge in metagenomic analysis…NewsNeurodegenerative Diseases: Metabolomics to Reveal Biomarkers for Early DiagnosisOn World Parkinson’s Day, it is essential to highlight not only the challenges faced by those diagnosed with this neurodegenerative disease but also to celebrate the scientific advances that open new avenues for early…NewsLiposcale Test: Use CasesChronic heart failure affects millions of people worldwide, representing one of the leading causes of morbidity and mortality in modern societies. Traditionally, the treatment and management of this condition have…NewsUnderstanding the Impact of Bariatric Surgery on Dyslipidemia and Cardiovascular Risk ReductionThe prevalence of obesity and its associated health risks, notably cardiovascular risk (CVD), is a global health concern. The interplay between obesity and cardiovascular diseases constitutes a complex health dilemma…NewsBiosfer Teslab at the forefront of NMR sample analysisAt Biosfer Teslab, we specialize in NMR sample analysis (Nuclear Magnetic Resonance). This revolutionary technology enables thorough examination of a wide range of biological samples, providing valuable insights into…NewsBreakthrough in Mediterranean Diet Research for Metabolic Syndrome PatientsA recent study published in the International Journal of Molecular Sciences, provides significant evidence on the benefits of the Mediterranean diet combined with physical activity for patients with metabolic syndrome…NewsExploring Metabolomics through Nuclear Magnetic Resonance and its Impact on Nutritional InterventionsMetabolomics, an emerging discipline in the biomedical research field, focuses on the comprehensive analysis of small metabolic molecules within a biological system. We explore its impact on nutritional interventions…NewsThe Importance of Branched-Chain Amino Acids (BCAAs) in Metabolism MonitoringBranched-chain amino acids (BCAAs), including valine, leucine, and isoleucine, play a crucial role in human metabolism, and their precise monitoring is essential for understanding and optimizing metabolic health. In…NewsMetBalance test: Monitor your metabolic health and revolutionize the way you take care of yourselfIn the modern era, concern for health and the prevention of non-communicable diseases has reached alarming proportions. With MetBalance test yoy can monitor your metabolic health. As sedentary lifestyles, unhealthy…NewsMetabolomics and Sexual Reproductive HealthThe Marató de TV3 has announced that the upcoming edition, scheduled for December 17, 2023, will focus on Sexual and Reproductive Health (SSIR), a crucial theme impacting millions in Catalonia and globally. In this…NewsWhat does metabolomics contribute to HIV research?Nuclear Magnetic Resonance (NMR) metabolomics emerges as a promising tool in HIV research due to its ability to provide a detailed insight into molecular changes in the body. By studying metabolomic profiles in…NewsGlycoproteins: Emerging Markers of InflammationCardiovascular events occur despite the control of conventional risk factors. Inflammation plays numerous roles in the pathogenesis of atherosclerotic cardiovascular disease. As an alternative to traditional…NewsWhat is metabolomics and how is it applied in diabetes?Metabolomic profiling involves identifying intermediary molecules and end-products of metabolism, encompassing lipids, lipoproteins, fatty acid variants, amino acids, and glycoprotein acetyls. This approach holds…NewsDiscordance between LDL-C levels and LDL particle numberLipoproteins are much more than just vehicles for cholesterol in our body. Although lipid analysis has traditionally focused on measuring levels of total, HDL, and LDL cholesterol, science has advanced, and we now know…NewsCardiovascular Disease: Beyond LDL CholesterolCardiovascular disease (CVD) claims the lives of over 4 million people in Europe every year. Dyslipidemia, a disorder characterized by abnormal blood lipid levels, is one of the most significant risk factors for the…NewsHow NMR metabolomics & artificial intelligence revolutionize neonatal health, clinical decision-making and diagnosisNMR metabolomics & AI in neonatal health Did you know that there are almost 3 million fetal and neonatal deaths every year? Did you know that Fetal growth restriction (FGR) is the largest contributor to stillbirth – the…NewsBiosfer Teslab launches MetBalance TestBiosfer Teslab develops MetBalance Test: an innovative blood test to monitor metabolic health and revolutionize the way you take care of yourself. Since its foundation in December 2013, Biosfer Teslab has been committed…NewsDiagnostic tool in infant and newborn healthLactApp On 25th, 26th and 27th May the LactApp Medical Congress took place under the slogan «Scientific evidence as a challenge in breastfeeding». LactApp is a company specialised in breastfeeding support. To this end…NewsOur lipoprotein and glycoprotein test in the SEA conferenceOn March 17th and 18th, the 17th Conference on Hypertriglyceridemia and the 8th Conference on lipid units organized by the Spanish Society of Arteriosclerosis (SEA) took place. Dra. Daiana Ibarretxe gave a presentation…NewsMetabolomics arrives at “The liver Meeting” comes from Biosfer TeslabFrom 12 to 15 November took place the “The liver Meeting” organised by the American Association for the Study of Liver Diseases (AASLD). The mission of the association is to advance and disseminate the science and…NewsBarça Innovation Hub: Metabolomics at the forefront of elite sportThe Barça Innovation Hub (BIHUB) was created four years ago by the FC Barcelona to develop technological advances applied to sport and improve performance at the highest level. This large Barça Laboratory aims to…NewsLiposcale for early and reliable diagnosis and prognosis of breast cancer patientsOne of the key features of malignant tumour cells is that their energy metabolism is altered. However, in recent years, alterations in lipid metabolism have been described in some types of cancer. A study led by the…NewsLiposcale in CirculationFrequent consumption of nuts, an important component of plant-based diets, is associated with a 15% reduction in total cardiovascular disease (CVD) and a 23% reduction in CVD mortality. Although small studies have shown…NewsImprovement in the prediction of atheromatous cardiovascular disease using the Liposcale testPatients with chronic kidney disease (CKD) have a high burden of atheromatous cardiovascular disease (ASCVD) that is not fully explained by traditional lipid parameters. A study published in the clinical Kidney journal…NewsBiosfer Teslab participates in a video of covid-19 researchLast week, in Biosfer Teslab, we participated in the video made as part of the URVGoals project, which shows different research being carried out at the URV with a common goal: to fight against the pandemic. The video…NewsThe use of Liposcale® Test in Premature Cardiovascular diseaseLast week, a new paper, which evaluates the use of the Liposcale® test as a predictor of premature cardiovascular disease (PRESARV-SEA Study), was published. Beyond levels of LDL-C, results reported in the article…NewsNuclear magnetic resonance-based metabolomic analysis in the assessment of preclinical atherosclerosis in type 1 diabetes and preeclampsiaDr. Amor and collaborators have published a new article in the Diabetes Research and Clinical Practice journal using our plasma metabolomics analysis. The aim of the study was to evaluate the role of plasma metabolomics…NewsFrom LAB to marketLast year we published 19 scientific articles in international journals. We are a metabolomics company halfway between research and clinical practice, a scientific research group in a business environment that is…NewsGlycA as a new biomarker in rheumatoid arthritisThe research group in Immunology at the University of Oviedo with the participation of Dr. Javier Rodríguez-Carrio has published a study in which one of the variables from our glycoprotein test has been identified as an…NewsOur Liposcale test in clinical practiceWe are very happy to announce that the Spanish Arteriosclerosis Society has drawn up a consensus on the clinical use of Nuclear Magnetic Resonance for the study of lipoproteins using our Liposcale® test. The Liposcale®…NewsLDL cholesterol: the poison is stored in small bottlesDr. Adriana Saltijeral of the University Hospital del Tajo (Aranjuez, Madrid) interviews Dr. Leopoldo Pérez de Isla, of the San Carlos Clinical Hospital of Madrid and member of the Scientific Committee of the Family…NewsStandard values of number and size of lipoprotein particles per age and gender, using Nuclear Magnetic ResonanceThe XXIX Convention of the Spanish Atherosclerosis Society (SEA) took place in Granada last May, and its scientific committee chose another of the I+D projects developed in Biosfer Teslab to be presented as an oral…NewsMetabolomics characterization for patients with Rheumatoid Arthritis using spectroscopyIn May, the XXIX Convention of the Spanish Atherosclerosis Society (SEA) took place in Granada, and its scientific committee chose one of the I+D projects developed in Biosfer Teslab to be presented as an oral…NewsEspecialists ask for the use in clinical practise of the new Lipoprotein determination testBiosfer Teslab took part in the XXIX National Convention of the Spanish Atherosclerosis Society (SEA), held this past May. Specifically, the Liposcale test was the main topic of the Round Table with the presence of…